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BACKGROUND: Spontaneously hypertensive rats develop left ventricular hypertrophy, increased blood pressure and blood pres-
sure variability, which are important determinants of heart damage, like the activation of renin-angiotensin system.
AIMS: To investigate the effects of the time-course of hypertension over 1) hemodynamic and autonomic patterns (blood pressure; 
blood pressure variability; heart rate); 2) left ventricular hypertrophy; and 3) local and systemic Renin-angiotensin system of the 
spontaneously hypertensive rats. 
METHODS: Male spontaneously hypertensive rats were randomized into two groups: young (n=13) and adult (n=12). Hemody-
namic signals (blood pressure, heart rate), blood pressure variability (BPV) and spectral analysis of the autonomic components 
of blood pressure were analyzed. LEFT ventricular hypertrophy was measured by the ratio of LV mass to body weight (mg/g), by 
myocyte diameter (µm) and by relative fibrosis area (RFA, %). ACE and ACE2 activities were measured by fluorometry (UF/min), 
and plasma renin activity (PRA) was assessed by a radioimmunoassay (ng/mL/h). Cardiac gene expressions of Agt, Ace and Ace2 
were quantified by RT-PCR (AU). 
RESULTS: The time-course of hypertension in spontaneously hypertensive rats increased BPV and reduced the alpha index in 
adult spontaneously hypertensive rats. Adult rats showed increases in left ventricular hypertrophy and in RFA. Compared to young 
spontaneously hypertensive rats, adult spontaneously hypertensive rats had lower cardiac ACE and ACE2 activities, and high levels 
of PRA. No change was observed in gene expression of Renin-angiotensin system components. 
CONCLUSIONS: The observed autonomic dysfunction and modulation of Renin-angiotensin system activity are contributing 
factors to end-organ damage in hypertension and could be interacting. Our findings suggest that the management of hypertensive 
disease must start before blood pressure reaches the highest stable levels and the consequent established end-organ damage is reached.
KEYWORDS: SHR; Hypertension; Blood pressure variability; RAS; LVH. 
INTRODUCTION
Left ventricular hypertrophy (LVH) and diastolic 
dysfunction are the early manifestations of cardiac damage 
in patients with arterial hypertension characterizing 
hypertensive heart disease.1 In response to a variety of 
mechanical, hemodynamic, hormonal and pathologic 
stimuli, the heart adapts to increased demands for cardiac 
work by increasing muscle mass through the compensatory 
hypertrophic response, which could lead to heart failure.1 
It is widely recognized that LVH is a powerful predictor 
86
CLINICS 2010;65(1):85-92Hypertension’s time course in SHR: RAS modulation 
Zamo FS et al.
of cardiovascular morbidity and mortality, independent 
from blood pressure (BP) levels and other cardiovascular 
risk factors.2 Indeed, the presence of LVH increases 
cardiovascular risk in hypertensive patients.3
It has been reported that increased BP and blood 
pressure variability (BPV) are both important determinants 
of heart damage.4,5 In addition, it has been demonstrated 
that BPV plays a crucial role in the modulation of end 
organ damage in hypertensive individuals and rats.6-8 
Indeed, SHR cardiac and vascular hypertrophy have been 
accompanied by autonomic dysfunction characterized by 
baroreflex dysfunction, decreased heart rate variability and 
consequently increased BPV. 4,7,8 
The renin-angiotensin system (RAS) is critical in 
regulating systemic blood pressure, water and electrolyte 
balance, and pituitary gland hormones, primarily by the 
angiotensin II/AT1 receptor subtype system. The importance 
of the RAS for the pathogenesis of hypertension is 
underscored by pharmacological interventions. Angiotensin 
converting-enzyme (ACE) inhibitors and angiotensin 
receptor antagonists have been used to attenuate or prevent 
the development of hypertension and its consequences on 
target organs.9-11 In fact, overstimulation of this system can 
predispose people to cardiovascular disease characterized 
by excessive vasoconstriction, fibrosis, and cardiac 
remodeling12. Nevertheless, few studies have provided 
explanations of how RAS is modulated during establishment 
and maintenance as well as during the time course of the 
hypertensive process.
This work was undertaken to investigate the effects 
of the time course of hypertension over 1) hemodynamic 
and autonomic patterns (blood pressure, blood pressure 
variability and heart rate); 2) LVH; and 3) local and systemic 
RAS of the spontaneously hypertensive rat (SHR). 
METHODS 
Animals: Male spontaneously hypertensive rats (SHR) 
were obtained from Central Bioterium of the Federal 
University of São Paulo, Brazil, at two different ages, four and 
twelve weeks old, were divided into two groups: young (n=13) 
and adult (n=12) rats. The experimental protocol for both 
groups started eight weeks before the determined ages. In this 
way, at the end of the protocol, the young group was twelve 
weeks old and the adult group was twenty weeks old. The 
twelve-week-old group (young) presented recently established 
hypertension, while the twenty-week-old group (adult) had 
suffered the consequences of hypertension for half of their 
lives, so we could compare different periods of established 
hypertension. The animals were housed in standard cages 
(four per cage), and food and water were provided ad libitum. 
The environmental temperature was kept at 23+1ºC, and 
a 12:12 dark-light cycle was maintained throughout the 
experiment. Every week, animals were weighed, and tail 
blood pressure was measured. This study was conducted in 
accordance with the ethical principles in animal research 
adopted by the Brazilian College of Animal Experimentation 
(COBEA). This research was approved by the Federal 
University of Sao Paulo Ethical Committee (#118/01).
Measurement of hemodynamic signals: Blood pressure 
(BP) and heart rate (HR) were measured indirectly 
during the time-course of the experimental protocol, and 
after eight weeks, they were measured directly. Indirect 
measurement was performed in both groups using a tail 
cuff every week. At the end of the study, the rats were 
anesthetized (ketamine, 90 mg/kg and xylazine, 10mg/kg; 
i.p.) and catheterized in the right femoral artery. Twenty-
four hours after catheterization, the signals of the resting BP 
of conscious rats were recorded (2 kHz) on a beat-to-beat 
basis using AT/CODAS (DataQ Instruments). A strain-gauge 
transducer (Statham P23 Db) was used for arterial pressure 
measurement. The transducer signal was fed to an amplifier 
(GPA-4, model 2, Stemtech) and then to a 10-bit analog-to-
digital converter, which interfaced with a computer. The HR 
was obtained from arterial BP pulses.
Blood Pressure and Pulse Interval Variability: Time-
domain analysis consisted of calculating the mean pulse 
interval (PI) and systolic blood pressure (SBP), as well 
as their variability as the standard deviation from their 
respective time series. In the frequency-domain analysis, 
Fast Fourier Transforming method (FFT) was used to 
evaluate systolic blood pressure, pulse interval and RR 
interval variability (SBPV and PIV, respectively). The 
spectral bands for rats (very low frequency (VLF): 0.0-
0.2 Hz; low frequency (LF): 0.2-0.75 Hz; high frequency 
(HF): 0.8-2.8 Hz) were defined according to previous 
references.13,14 Spectral power for LF and HF bands was 
calculated by means of power spectrum density integration 
within each frequency bandwidth. The power density of 
each spectral component was calculated both in absolute 
values and in normalized units.15 Power in LF and in HF for 
pulse intervals was normalized by calculating the variance 
minus the power in very low frequency (VLF) and were 
expressed in normalized units (nu). The sympatho-vagal 
balance was defined by the LFnu/HFnu ratio. The LF 
components of the PIV and LF components of the SBPV 
were considered markers of efferent sympathetic cardiac 
and vascular modulation, respectively, whereas the HF 
component of the PIV reflected respiratory-driven vagal 
modulation to the sinoatrial node.15 For frequency-domain 
analysis, the entire ten-minute time series of blood pressure 
and pulse, or RR intervals, were evaluated under basal 
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conditions using non-parametric methods (FFT), described 
in detail above. Beat-to-beat values of SBP and PI intervals 
were used to estimate the cardiac baroreflex sensitivity 
(BRS) by spectral analysis, using the alpha index for the 
low-frequency band (0.20–0.75 Hz). The alpha index 
analysis evaluates short-term changes in the systolic blood 
pressure and in the RR interval. This method has been 
proposed to quantify cause-and-effect events linked with 
the baroreflex. Indeed, several studies showed a good 
correlation between the alpha index and the consequences 
of systemic phenylephrine infusions.16
The coherence between the PI and the SBP signal 
variability was assessed by means of a cross-spectral 
analysis. The alpha index in the LF band was calculated only 
when the magnitude of the squared coherence between the PI 
and SBP signals exceeded 0.5 (range, 0–1). After coherence 
calculation, the alpha index was obtained from the square 
root of the ratio between PI and SBP variability in the two 
major LF bands.
Cardiac hypertrophy: Twenty-four hours after 
hemodynamic measurements, rats were killed by 
decapitation, and their hearts were initially perfused with 
10 ml of phosphate buffered saline to wash out the blood. 
After the hearts were stopped at diastole by perfusion with 
14 mM KCl, the Left Ventricle (LV; free wall plus septum) 
was obtained as the tissue remaining after removal of both 
atria and the free wall of the right ventricle RV. Afterwards, 
the cardiac chambers were weighed. For determination of 
cardiac hypertrophy, the LV weight (LVW), RV weight 
and atria weight were normalized by body weight (BW) 
to evaluate relative cardiac mass (LVW/BW in mg/g). 
The LV was submitted to histological evaluation by 
measuring myocyte diameter and relative fibrosis area. For 
histological preparation, tissues were immersion-fixed in 
4% formaldehyde and embedded in paraffin, cut into 5 µm 
sections at the level of the papillary muscle and subsequently 
stained with either hematoxylin-eosin (HE) for cellular 
structure visualization (to measure myocyte diameter), or 
with picrosirius (to measure relative fibrosis area). For each 
evaluation, two randomly selected sections from each LV 
were visualized by light microscopy at 400X magnification. 
Myocytes with visible nuclei and intact cellular membranes 
were chosen for diameter determination. The widths of 
individually isolated cardiomyocytes were manually 
traced across the middle of the nuclei and displayed on a 
viewing screen with a digitizing pad and determined by a 
computer-assisted image analysis system (Quantimet 520; 
Cambridge Instruments, Cambridge, UK). For each animal, 
approximately 20 visual fields were analyzed, and the 
observer was blinded to the experimental groups.
Myocardial interstitial relative fibrosis area (RFA) was 
determined by analyzing the picrosirius-prepared slices 
through polarized light, as previously reported17. In brief, 
the sections were analyzed using a microscope with 200X 
magnification. Twenty fields were selected, and interstitial 
collagen was determined by a computer-assisted image 
analysis system (Quantimet 520; Cambridge Instruments), 
by an observer blinded to the experimental groups. RFA 
was calculated as a relation of positive collagen area divided 
by the muscle area in all fields. Perivascular collagen was 
specifically excluded from this determination. 
Serum and Tissue Samples: Blood was collected from the 
neck wound and centrifuged (1,500 g, 15 min at 4°C). Blood 
was collected without an anticoagulant for an ACE activity 
assay. To determine plasma renin activity and angiotensin II 
(Ang II) levels, the first 3 mL of trunk blood were rapidly 
collected into chilled glass tubes containing a mixture of 
potassium EDTA (25 mM), o-phenanthrolene (0.44 mM), 
pepstatin A (0.12 mM), and 4-chloromercuribenzoic acid (1 
mM). This mixture of protease inhibitors prevented the in 
vitro production and degradation of angiotensin peptides.18 
The blood was centrifuged, and the plasma or serum were 
separated and stored at -20oC. Hearts were dissected, and 
atria, right and left ventricles were isolated and weighed. 
Left ventricles (LV) were stored at -80oC until biochemical 
and molecular analysis.
Measurement of Ang II: Plasma samples were passed 
through phenyl silica cartridges (Sep-Pak C18 columns, 
Waters, Milford, Massachusetts, USA), and the absorbed 
angiotensin was eluted with methanol. Eluate was dried 
in a vacuum centrifuge, and the pellet was resuspended 
in Enzyme ImmunoAssay buffer (EIA buffer), mixed, and 
centrifuged at 3,000 g for 10 min at 4°C. ANG II levels 
were determined by ELISA, according to the manufacturer’s 
instructions (SPI-BIO). The protein content was determined 
by the Bradford method (19) by using bovine serum albumin 
as the standard (Bio-Rad Protein Assay).
 Serum and heart ACE and ACE2 activity: ACE and 
ACE2 activities were determined by a fluorimetric assay 
based on the rate of generation of His-Leu by hydrolysis of 
Hippuryl-His-Leu substrate, as previously reported19. Hearts 
were quickly harvested, rinsed, and homogenized in Tris-
HCl buffer, pH 7.0, containing 50 mM NaCl. Homogenates 
were centrifuged at 1000 g for 10 min, and the supernatant 
was frozen at -20ºC. The protein contents of the samples 
were measured by Bradford assay using bovine serum 
albumin as the standard.20
Plasma renin activity (PRA) assay: PRA was measured by 
the angiotensin I radioimmunoassay, using a commercial kit 
(REN-CT2, CIS Bio International). This assay permits a direct 
measure of PRA. Results were quantified in a Gama Counter, 
and the enzyme activity was expressed as ng/mL/h of Ang I.
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Quantification of mRNA levels by real-time polymerase 
chain reaction (PCR): Total RNA was isolated from 
frozen LV samples according to the manufacturer’s 
guidelines. Reverse-transcription and real-time PCR 
were performed as previously reported.21,22 Briefly, total 
RNA (2µg) samples from the experimental groups were 
simultaneously reverse-transcribed using a master mix 
containing oligo(dT) primer and SuperScript II reverse 
transcriptase (Invitrogen) in a final volume of 20 l. cDNA 
was treated with 2U of RNase H (Invitrogen) at 37ºC for 
20 min. Specific primers for the genes Ace (NM_012544), 
Ace2 (NM_001012006), Agt (NM_134432) and the control 
gene cyclophilin A (peptidylprolyl isomerase A: Ppia, 
NM_017101) were designed using the Primer3 software 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.
cgi). Forward and reverse primers were positioned 
in different exons, and specificity was confirmed by 
a BLAST search (software-assisted search of a non-
redundant nucleotide sequence database for rat at http://
www.ncbi.nlm.nih.gov/BLAST). Primers (synthesized 
by Invitrogen, Sao Paulo, Brazil) had the following 
sequences: rAceF: 5’-CAGGAACGTGGAACTTGGA–3’, 
r A c eR :  5 ’ - CTTTGACGGAAGCATCACC - 3 ’ , 
e x p e c t e d  p r o d u c t  s i z e  =  1 3 4 b p ;  r A c e 2 F : 
5 ’ -CGCTGTCACCAGACAAGAA-3 ’ ,  rAce2R : 
5’-GCCATTATTTCGTCCAATCC-3´, expected product 
size: 139bp; rAgtF: 5’- TCTACCCTTTTGGGTGCTG-3’, 
rAg tR :  5 ’ -CAAGGAGGATGCTGTTGAGA-3 ’ , 
e x p e c t e d  p r o d u c t  s i z e :  8 8 b p ;  a n d  r P p i a F : 
5 ´ -AATGCTGGACCAAACACAAA-3´ ,  rPp iaR: 
5´-CCTTCTTTCACCTTCCCAAA-3´, expected product 
size: 101bp. The relative mRNA expression levels were 
quantified by an ABI PRISM 7700 Sequence Detection 
System (SDS) (Applied Biosystems), using the SYBR 
green methodology. cDNA samples were processed in 
triplicate for each transcript, and samples without cDNA 
templates or primers were included as negative controls. 
The relative expression level of each mRNA in the left 
ventricle between young and adult rats was calculated 
according to Vandesompele et al (2002) .23 Briefly, the 
arithmetic mean of the replicated cycling threshold (Ct) 
value of each amplicon was transformed to a quantity 
relative to the sample with the highest expression, taking 
into account the amplification efficiency of each gene. 
The raw quantities were subsequently normalized by the 
reference gene Ppia. 
Statistical Analysis: All values are presented as 
mean±standard error. The results were analyzed by 
a t-test. A p value of less than 0.05 was considered 
significant.
RESULTS
Blood pressure, heart rate and blood pressure variabil-
ity evaluations
The indirect BP evaluation performed during the protocol 
showed an increase in systolic blood pressure (SBP) in 
the young group (12 weeks old), while the adult group 
maintained hypertension until 20 weeks of age (figure 1A). 
The direct hemodynamic evaluation confirmed the increase 
of resting values of diastolic blood pressure (DBP), systolic 
blood pressure (SBP), and mean blood pressure (MBP) in 
adults, when compared to young rats (figure 1B). 
In addition, our data showed increased systolic blood 
pressure variability in adult rats, which was accompanied 
by an increased LF component of systolic blood pressure 
variability when compared to young SHR. Moreover, 
a marked reduction in the alpha index in the adult rats 
indicates an age-associated progressive reduction in 
baroreflex control of circulation in these animals. 
Table 1 shows the results obtained by direct 
measurements. 
Figure 1 - Indirect and direct blood pressure (BP) measurements. A: tail 
systolic blood pressure in young and adult rats during experiment. Observe 
the BP stabilization between the 10th and 12th weeks of age. B: direct systolic 
BP (SBP), mean BP (MBP) and diastolic BP (DBP) in young and adult rats. 
Observe that adult rats presented increases in BP. * p≤ 0.05
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Cardiac hypertrophy
To determine the presence and extent of cardiac 
hypertrophy, it was necessary to measure body weight. 
Body weight (BW) increased in young animals and reduced 
in adults. Young rats started with a weight of 66±3 g and 
finished with a weight of 236±5 g, while adult rats started at 
221±5 g and finished at 167±5 g. It is important to reiterate 
that body weight was used at the end of the experiment to 
calculate relative mass of cardiac atria, RV and LV.
The development of heart hypertrophy was investigated 
by means of the atria weight/BW, RV weight/BW, and LV 
weight/BW ratios. The LVW/BW ratio was increased in adult 
rats when compared to young rats (2.86±0.04 vs. 2.63±0.05 
mg/g, respectively, p=0.001). Atria weight/BW (0.17±0.01 
vs. 0.15±0.01 mg/g, in adult rats) and RV/BW (0.72±0.03 
vs. 0.63±0.03 mg/g, in adult rats) ratios were not different 
between the groups. Additionally, the adults showed a 
significant increase in myocyte diameter compared to young 
rats (18.2±0.48 vs. 12.5±0.3 µm, respectively, p<0.00001). 
To evaluate whether cardiac hypertrophy was 
accompanied by cardiac fibrosis, collagen characteristics 
were evaluated by the relative fibrosis area. In Table 2, the 
collagen quantification showed that interstitial RFA was 
three-fold increased in adult rats when compared to young 
rats (1.51±0.17 vs. 0.52±0.05%, p=0.001).
Biochemical and molecular analysis of the renin-angio-
tensin system 
Renin-angiotensin system component activities were 
studied in serum, plasma and hearts. As shown in Table 3, 
both serum Ace activity and angiotensin II levels did not 
change. Moreover, both heart ACE and ACE2 activities 
decreased in adult rats, while plasma renin activity increased. 
On the other hand, angiotensinogen, Ace and Ace2 gene 
expression in the heart did not change between young and 
adult rats.
DISCUSSION
As expected, blood pressure and systolic blood pressure 
variability were increased in older SHR (20 weeks old) 
in comparison with young rats (12 weeks old), indicating 
progressive activation of hypertensive mechanisms by either 
sympathetic activity and/or the renin-angiotensin systems 
in these rats, a fact also documented in humans.24 Although 
previous studies have evaluated BP rhythms in hypertensive 
rats, information regarding hemodynamic changes during the 
time-course of hypertension is not very consistent.25 This is 
probably due to the different methods used to measure BP as 
well as the age of the animals used in each study. El Mas and 
colleagues (2005),26 using telemetry monitoring, observed 
in 14-27-week-old SHR similar results to those observed 
in the present study, but they did not analyze any structural 
alterations. They also did not have any data on the rats before 
the establishment of stable hypertension.
Table 1 - Baroreflex sensitivity (alpha index), pulse interval 
variability (PIV) and systolic blood pressure variability 
(SBPV) in time and frequency domains (low frequency, LF 
and high frequency, HF)
Young (n=7) Adult (n=8)
PIV (ms2 ) 78.73±12.25 65.75±10.08
SBPV (mmHg2) 47.93±8.32 77.96±9.06 *
LF of SBPV (mmHg2) 9.49±1.95 22.34±3.26 *
HF of SBPV (mmHg2) 2.61±0.63 5.64±1.17 *
Alpha LF index (ms/mmHg) 0.76±0.1 0.49±0.07 *
Data are shown as mean±SEM. * p≤0.05
Table 2 - Histological analysis of LV myocyte diameter and 
relative fibrosis area (RFA)
Y (n=5) A (n=6)
LV Myocyte 
(m)
12.46 + 0.30 18.24 + 0.48*
RFA 
(%)
0.52 + 0.05 1.51 + 0.17*
Y: young (n=5); A: adult (n=6). * p<0.001.
Table 3 - Expression and activity of renin-angiotensin system 
components
Young (n=8) Adult (n=8)
Serum ACE activity (UF/min/mL) 28228±716 28040±712
Heart ACE activity (UF/min/mg) 1579±108 1010±86 *
Heart ACE2 activity (UF/min/mg) 769±99 622±76 *
Plasma renin activity (ng/mL/h) 0.45±0.07 1.36±0.05 *
Angiotensin II (pg/mL) 42.5±0.77 42.1±1.39
Angiotensinogen expression (AU) 0.771±0.111 1.103±0.266
Heart Ace expression (AU) 0.945±0.155 0.965±0.197
Heart Ace2 expression (AU) 0.815±0.231 0.761±0.148
Data are shown as mean±SEM. *p<0.05
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Moreover, it is well known that the complications of 
hypertension, including end-organ damage and microvascular 
rarefaction, are related not only to an increase in BP levels 
but also to changes in BP fluctuations around the mean BP 
values.27,28 In the present study, we have observed an increase of 
63% in SBPV in adult SHR when compared to the young SHR 
group, indicating impairment of the BP control mechanisms 
from 12 to 20 weeks during the time course of hypertension 
in SHR. These changes in SBPV were accompanied by the 
maintenance of hypertension, with values that were kept at the 
highest levels observed in this experiment. The mechanism of 
this impairment may be attributed to an increase in sympathetic 
modulation to the vessels, probably associated with reduced 
baroreflex sensitivity observed in young SHR and also impaired 
in adults. In fact, a 100% enhancement in the LF component of 
SBPV may account for worsened BP control while no changes 
were observed in HR variability, (VPI). Similarly, an increase 
of 50% in BPV was observed in adult SHR (17-24 weeks 
old) when compared with WKY controls at the same age,25 
indicating a role for hypertension in the development of this 
pathophysiological adjustment.
Interestingly, age-related changes in hypertension as well 
as changes in the neurogenic mechanisms of BP control are 
associated with the development of LV cardiac hypertrophy. In 
fact, not only hypertension but also BPV have been associated 
with the severity of end-organ damage on a longitudinal basis.29 
In addition, LV myocyte diameter and collagen quantification 
were proportionally increased in 20-week-old SHR when 
compared with the young group, reinforcing the age-related 
activation of remodeling mechanisms in the heart of these 
hypertensive animals. In contrast, changes in the atrium and 
RV weight were not detected in either observation period in this 
study, suggesting that it was too early to observe alterations in 
these heart structures.
The findings regarding activity of the renin-angiotensin 
system showed that some components are activated in young 
SHR, at the beginning of hypertension, and this activation is 
unchanged in adult rats. Recently, Li et al. (2008)30 showed 
that gene expression of RAS components is increased in SHR 
compared to normotensive Wistar rats. However, the observation 
of decreased ACE activity in the adult heart may be related to 
an adaptation to hypertrophy, corroborating the finding of Li 
et al. (2008)30 who also showed that Ace gene expression in 
adult SHR was not different from that of normotensive rats. On 
the other hand, the decrease of ACE2 activity is also probably 
related to the heart hypertrophy due to the possible loss of 
protective mechanisms in hypertensive rats. It is important 
to consider that ACE and ACE2 tissue activity regulation are 
occurring in the hypertrophied hearts of hypertensive rats. 
Furthermore, these decreases in activities are not accompanied 
by changes in gene expression (as shown in Table 3).
Another important finding is that plasma renin activity is 
increased in adult rats, suggesting that the RAS activation is 
due to the well-described neurogenic hypertension in SHR31. 
This RAS activation may not be essential during the adaptation 
to hypertension, but it must be essential in a late process, either 
related to heart failure32 or to vascular injury.33
The renin-angiotensin system and the autonomic system 
have a bidirectional relationship, and it is difficult to separate 
their effects in order to differentiate the sequence of events. 
Both the sympathetic nervous system and RAS are important 
blood pressure regulatory factors.34,35 Angiotensin receptors and 
other components of the RAS cascade are widely distributed in 
the brain36 and exert a stimulatory influence on the sympathetic 
nervous system. Sympathetic hyperactivity is associated with an 
increase in RAS, while baroreflex sensitivity is influenced by 
RAS vasoactive peptides.36,37 Therefore, the interactions of both 
systems are responsible for the cardiovascular derangements 
observed in hypertension. It is known that local RAS plays 
a key role in the cardiac hypertrophy process.30 Additionally, 
both increased BP and blood pressure variability (BPV) are 
important factors that stimulate the overactivity of local RAS, 
although BPV seems to play a larger role.38 Considering that 
sympathetic hyperactivity could be a causal factor of RAS and 
autonomic dysfunction, we may consider it to maintain the 
functionality of both dysfunctions. 
CONCLUSION
The findings of the present study demonstrated that BP 
increased during the observation period of young SHR (from 4 
to 12 weeks of age), while it was maintained at an elevated level 
between the 12th to 20th weeks of age in the adult group. It is 
important to highlight that these differences were accompanied 
by increases in SBPV, cardiac hypertrophy and PRA, alongside 
decreases in baroreflex sensitivity and in heart tissue ACE 
and ACE2 activities. These observations may indicate that 
autonomic dysfunction and RAS activity are contributing 
factors to end-organ damage in hypertension, which have 
probably influenced additional impairment in autonomic 
dysfunction by changing vessels and heart structures. All these 
findings strongly suggest that the management of hypertensive 
disease must be started before BP reaches its highest stable 
levels and before resultant end-organ damage is established.
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